» Articles » PMID: 26963710

Parameterization for In-Silico Modeling of Ion Channel Interactions with Drugs

Overview
Journal PLoS One
Date 2016 Mar 11
PMID 26963710
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Since the first Hodgkin and Huxley ion channel model was described in the 1950s, there has been an explosion in mathematical models to describe ion channel function. As experimental data has become richer, models have concomitantly been improved to better represent ion channel kinetic processes, although these improvements have generally resulted in more model complexity and an increase in the number of parameters necessary to populate the models. Models have also been developed to explicitly model drug interactions with ion channels. Recent models of drug-channel interactions account for the discrete kinetics of drug interaction with distinct ion channel state conformations, as it has become clear that such interactions underlie complex emergent kinetics such as use-dependent block. Here, we describe an approach for developing a model for ion channel drug interactions. The method describes the process of extracting rate constants from experimental electrophysiological function data to use as initial conditions for the model parameters. We then describe implementation of a parameter optimization method to refine the model rate constants describing ion channel drug kinetics. The algorithm takes advantage of readily available parallel computing tools to speed up the optimization. Finally, we describe some potential applications of the platform including the potential for gaining fundamental mechanistic insights into ion channel function and applications to in silico drug screening and development.

Citing Articles

The conductance of KCNQ2 and its pathogenic variants is determined by individual subunit gating.

Hinojo-Perez A, Eldstrom J, Dou Y, Marinho-Alcara A, Edmond M, de la Cruz A Sci Adv. 2025; 11(10):eadr7012.

PMID: 40043113 PMC: 11881901. DOI: 10.1126/sciadv.adr7012.


A novel computational model of swine ventricular myocyte reveals new insights into disease mechanisms and therapeutic approaches in Timothy Syndrome.

Trancuccio A, Tarifa C, Bongianino R, Priori S, Santiago D Sci Rep. 2024; 14(1):29792.

PMID: 39616198 PMC: 11608236. DOI: 10.1038/s41598-024-80726-2.


A Reinterpretation of the Relationship between Persistent and Resurgent Sodium Currents.

Brown S, Lawson R, Moreno J, Ransdell J J Neurosci. 2024; 44(29).

PMID: 38858080 PMC: 11255426. DOI: 10.1523/JNEUROSCI.2396-23.2024.


Evaluating sequential and allosteric activation models in IKs channels with mutated voltage sensors.

Fedida D, Sastre D, Dou Y, Westhoff M, Eldstrom J J Gen Physiol. 2024; 156(3).

PMID: 38294435 PMC: 10829594. DOI: 10.1085/jgp.202313465.


A Reinterpretation of the Relationship Between Persistent and Resurgent Sodium Currents.

Brown S, Lawson R, Moreno J, Ransdell J bioRxiv. 2024; .

PMID: 38187680 PMC: 10769191. DOI: 10.1101/2023.10.25.564042.


References
1.
Horn R, Vandenberg C . Statistical properties of single sodium channels. J Gen Physiol. 1984; 84(4):505-34. PMC: 2228752. DOI: 10.1085/jgp.84.4.505. View

2.
Clancy C, Rudy Y . Linking a genetic defect to its cellular phenotype in a cardiac arrhythmia. Nature. 1999; 400(6744):566-9. DOI: 10.1038/23034. View

3.
Lu H, Rohrbacher J, Vlaminckx E, Van Ammel K, Yan G, Gallacher D . Predicting drug-induced slowing of conduction and pro-arrhythmia: identifying the 'bad' sodium current blockers. Br J Pharmacol. 2010; 160(1):60-76. PMC: 2860207. DOI: 10.1111/j.1476-5381.2010.00646.x. View

4.
Balser J . Structure and function of the cardiac sodium channels. Cardiovasc Res. 1999; 42(2):327-38. DOI: 10.1016/s0008-6363(99)00031-0. View

5.
Liu H, Tateyama M, Clancy C, Abriel H, Kass R . Channel openings are necessary but not sufficient for use-dependent block of cardiac Na(+) channels by flecainide: evidence from the analysis of disease-linked mutations. J Gen Physiol. 2002; 120(1):39-51. PMC: 2311398. DOI: 10.1085/jgp.20028558. View